InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-22.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Helsel Dave, Vice-Président Senior, Opérations Globales et R&D. Officer active across 1 company, notably Angiodynamics INC. In total, 20 disclosures have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €408k. History available since 14 July 2021. The latest transaction was filed on 19 July 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
9,650 shares0Common StockSEC:0001140361-23-044839:0
4,371 shares0Common StockSEC:0001140361-23-036321:0
332 shares@ US$8.740.6% of flowCommon StockSEC:0001140361-23-036119:0
365 shares@ US$8.650.6% of flowCommon StockSEC:0001140361-23-036119:1
10,789 shares0Common StockSEC:0001140361-23-035731:0
679 shares@ US$9.631.3% of flowCommon StockSEC:0001140361-23-035083:0
313 shares@ US$9.560.6% of flowCommon StockSEC:0001140361-23-035083:1
4,633 shares@ US$12.9512.3% of flowCommon StockSEC:0001567619-23-001649:0
5,000 shares@ US$22.4424.4% of flowCommon StockSEC:0001567619-22-014709:0
3,691 shares0Common StockSEC:0001567619-22-014373:0
3,480 shares0Common StockSEC:0001567619-22-013850:0
3,513 shares@ US$22.440.017% mcap27.7% of flowCommon StockSEC:0001567619-22-009209:0
3,494 shares@ US$27.970.019% mcap30.9% of flowCommon StockSEC:0001567619-21-018544:0
3,494 shares@ US$27.9718.6% of flowCommon StockSEC:0001567619-21-018544
11,406 shares0Common StockSEC:0001567619-21-016019
11,406 shares0Common StockSEC:0001567619-21-016019:0
2,685 shares0Common StockSEC:0001567619-21-015952
2,685 shares0Common StockSEC:0001567619-21-015952:0
640 shares@ US$26.433.2% of flowCommon StockSEC:0001567619-21-013925
640 shares@ US$26.430.0032% mcap5.3% of flowCommon StockSEC:0001567619-21-013925:0
20 of 20 declarations
About Helsel Dave
Dave Helsel is the Senior Vice President of Global Operations and R&D at AngioDynamics Inc. He plays a key role in optimizing operations and product innovation, ensuring that the company remains at the forefront of medical technologies. His expertise in operational management is crucial for the company's success.
